Document Classification

Section Type: RESULTS

Text: After treatment, there was much better improvement in symptom score (2. 4 + / - 0. 9 vs 3. 1 + / - 0. 9, P < 0. 01), symptomatic days due to rhinitis (4. 0 + / - 1. 2 d/week vs 1. 9 + / - 0. 9 d/week, P < 0. 001), episode of common cold symptom (0. 8 + / - 0. 5 time vs 1. 1 + / - 0. 4 time, P < 0. 001), average doses of inhaled beta (2) agonist as rescue medication (2. 6 + / - 0. 9 puff/week vs 3. 7 + / - 0. 8 puff/week, P < 0. 001) and bronchial responsiveness (P < 0. 05) in Loratadine group as compared with the control group.